{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:21:26Z","timestamp":1775636486090,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jpba.2017.08.024","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T02:45:16Z","timestamp":1505789116000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Immediate hypersensitivity to penicillins. Identification of a new antigenic determinant"],"prefix":"10.1016","volume":"148","author":[{"given":"Sonia","family":"Matas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Broto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Corominas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Lleonart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Babington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-Pilar","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Galve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.08.024_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IDR.S55778","article-title":"Agriculture and food animals as a source of antimicrobial-resistant bacteria","volume":"8","author":"Economou","year":"2015","journal-title":"Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.jpba.2017.08.024_bib0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/pr.113.007450","article-title":"Idiosyncratic adverse drug reactions: current concepts","volume":"65","author":"Uetrecht","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.jpba.2017.08.024_bib0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1471-4906(03)00142-X","article-title":"The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation","volume":"24","author":"Rajan","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jpba.2017.08.024_bib0020","unstructured":"http:\/\/www.eaaci.org\/organisation\/about-us\/introduction.html."},{"issue":"5\u20136","key":"10.1016\/j.jpba.2017.08.024_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00253-003-1274-y","article-title":"Industrial production of b-lactam antibiotics","volume":"61","author":"Elander","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jpba.2017.08.024_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/ja.2008.16","article-title":"Microbial drug discovery: 80 years of progress","volume":"62","author":"Demain","year":"2009","journal-title":"J. Antibiot."},{"issue":"476","key":"10.1016\/j.jpba.2017.08.024_bib0035","first-page":"1","article-title":"Penicillin and beta-lactam allergy: epidemiology and diagnosis","volume":"14","author":"Macy","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"3","key":"10.1016\/j.jpba.2017.08.024_bib0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.iac.2004.03.010","article-title":"Classification and epidemiology of hypersensitivity drug reactions","volume":"24","author":"Demoly","year":"2004","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.jpba.2017.08.024_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinte.161.1.15","article-title":"Anaphylaxis in the United States: an investigation into its epidemiology","volume":"161","author":"Neugut","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jpba.2017.08.024_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11882-005-0048-2","article-title":"Update on beta-lactam allergy diagnosis","volume":"5","author":"Demoly","year":"2005","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jpba.2017.08.024_bib0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1034\/j.1398-9995.2003.00280.x","article-title":"Diagnosis of immediate allergic reactions to beta-lactam antibiotics","volume":"58","author":"Torres","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jprot.2012.09.030","article-title":"Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum","volume":"77","author":"Ariza","year":"2012","journal-title":"J. Proteomics"},{"key":"10.1016\/j.jpba.2017.08.024_bib0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/tx000226f","article-title":"Studies of the chemical selectivity of Hapten reactivity, and skin sensitization potency. 2. NMR studies of the covalent binding of the 13C-labeled skin sensitizers 2-[13C]- and 3-[13C]hex-1-ene- and 3-[13C]hexane-1,3-sultones to human serum albumin","volume":"14","author":"Meschkat","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2017.08.024_bib0070","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.tiv.2008.03.006","article-title":"Mass spectrometric identification of covalent adducts of the skin allergen 2,4-dinitro-1-chlorobenzene and model skin proteins","volume":"22","author":"Aleksic","year":"2008","journal-title":"Toxicol. In Vitro"},{"issue":"22","key":"10.1016\/j.jpba.2017.08.024_bib0075","first-page":"6","article-title":"A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine","volume":"2009","author":"Jenkinson","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2017.08.024_bib0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tiv.2009.01.014","article-title":"Mechanistic assessment of peptide reactivity assay to predict skin allergens with Kathon\u00ae CG isothiazolinones","volume":"23","author":"Mutschler","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.jpba.2017.08.024_bib0085","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1016\/j.bmc.2008.04.014","article-title":"Sensitization to p-amino aromatic compounds: study of the covalent binding of 2,5-dimethyl-p-benzoquinonediimine to a model peptide by electrospray ionization tandem mass spectrometry","volume":"16","author":"Eilstein","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2017.08.024_bib0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/toxsci\/kfr101","article-title":"The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments","volume":"122","author":"Troutman","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jpba.2017.08.024_bib0095","first-page":"165","article-title":"Preparation of benzylpenicilloyl-polylysine: a preliminary study","volume":"25","author":"Vemuri","year":"2004","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.jpba.2017.08.024_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/rcm.4823","article-title":"Identification of new minor metabolites of penicillin G in human serum by multiple-stage tandem mass spectrometry","volume":"25","author":"Ho","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2017.08.024_bib0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1021\/bc0155824","article-title":"Dendrimers as carrier protein mimetics for IgE antibody recognition. Synthesis and characterization of densely penicilloylated dendrimers","volume":"13","author":"S\u00e1nchez-Sancho","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpba.2017.08.024_bib0110","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/tx500210e","article-title":"Mass spectrometric strategies for the identification and characterization of human albumin covalently adducted by amoxicillin: ex vivo studies","volume":"27","author":"Garzon","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2017.08.024_bib0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cea.12468","article-title":"Management of allergy to penicillins and other beta-lactams","volume":"45","author":"Mirakian","year":"2015","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0120","series-title":"Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People","author":"N.C.G.C. (UK)","year":"2014"},{"key":"10.1016\/j.jpba.2017.08.024_bib0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ACI.0000000000000173","article-title":"Penicillin allergy: optimizing diagnostic protocols, public health implications, and future research needs","volume":"15","author":"Macy","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"459","key":"10.1016\/j.jpba.2017.08.024_bib0130","first-page":"1","article-title":"Evaluation of antibiotic allergy: the role of skin tests and drug challenges","volume":"14","author":"Solensky","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jpba.2017.08.024_bib0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3949\/ccjm.78a.11023","article-title":"Allergy blood testing: a practical guide for clinicians","volume":"78","author":"Siles","year":"2011","journal-title":"Clev. Clin. J. Med."},{"key":"10.1016\/j.jpba.2017.08.024_bib0140","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1398-9995.2011.02661.x","article-title":"The in vitro diagnosis of drug allergy: status and perspectives","volume":"66","author":"Ebo","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0145","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/1744666X.2014.959498","article-title":"Basophil activation tests: time for a reconsideration","volume":"10","author":"Uyttebroek","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jpba.2017.08.024_bib0150","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00508-009-1187-6","article-title":"The specificity of tests for anti-b-lactam IgE antibodies declines progressively with increase of total serum IgE","volume":"121","author":"Zidarn","year":"2009","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.jpba.2017.08.024_bib0155","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2222.2009.03219.x","article-title":"Influence of total serum IgE levels on the in vitro detection of b-lactams-specific IgE antibodies","volume":"39","author":"Vultaggio","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-017-0144-0","article-title":"Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America","volume":"7","author":"Torres","year":"2017","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0165","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1398-9995.2006.01268.x","article-title":"Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy","volume":"62","author":"Fontaine","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jpba.2017.08.024_bib0175","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0040-4039(00)84089-7","article-title":"Diketopiperazine formation in solid phase peptide synthesis using p-alkoxybenzyl ester resins and Fmoc-amino acids","volume":"27","author":"Pedroso","year":"1986","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jpba.2017.08.024_bib0180","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.bmcl.2005.01.017","article-title":"Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic","volume":"15","author":"Shi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jpba.2017.08.024_bib0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0014-5793(73)80710-0","article-title":"Base-promoted cleavage of a-N-NBD-peptides","volume":"34","author":"Aboderin","year":"1973","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jpba.2017.08.024_bib0190","unstructured":"www.iedb.org\/epId\/116053 (Immune epitope database and analysis resource)."},{"key":"10.1016\/j.jpba.2017.08.024_bib0195","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1039\/P19870002361","article-title":"Total synthesis of analogues of the b-lactam antibiotics. Part 3. 2-Ethoxycarbonyl derivaties of carbapen-1-em-exo-carboxylates and carbapenam-3-exo-carboxylates","volume":"111","author":"Sharma","year":"1987","journal-title":"J. Chem. Soc. Perkin Trans."},{"issue":"2","key":"10.1016\/j.jpba.2017.08.024_bib0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/p29860000349","article-title":"A 1H, 13C, and 19F nuclear magnetic resonance study of rotational isomerism and long-range coupling in methyl (1S,5R,7R)-1-ethyl-3-oxo-6-trifluoroacetyl-2,8-dioxa-6-azabicyclo[3.2.1]octane-7-carboxylate","volume":"2","author":"Everett","year":"1986","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.jpba.2017.08.024_bib0205","series-title":"The Chemistry of Penicillin","author":"Clarke","year":"1949"},{"key":"10.1016\/j.jpba.2017.08.024_bib0210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.foodcont.2014.11.043","article-title":"Immunochemical detection of penicillins by using biohybrid magnetic particles","volume":"51","author":"Broto","year":"2015","journal-title":"Food Control"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517315947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517315947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:26:10Z","timestamp":1731720370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517315947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":42,"alternative-id":["S0731708517315947"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.08.024","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immediate hypersensitivity to penicillins. Identification of a new antigenic determinant","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}